The American Recovery and Reinvestment Act of 2009 aims to accelerate the adoption of health information technology through the federal incentive program commonly referred to as Meaningful Use (MU). MU provides incentive payments to eligible professionals (EP) and eligible hospitals (EH) that are able to demonstrate the “meaningful use” of electronic health records technology. EPs and EHs must demonstrate MU through a number of objectives. A small portion of those objectives are related to reporting data to public health agencies.
The Florida Department of Health’s (FDOH) Bureau of Epidemiology leads the effort to on-board eligible hospitals for reportable lab results (RLR) reporting and syndromic surveillance reporting. For more information about reporting Immunizations data to FDOH for Meaningful Use contact the Bureau of Immunizations at FLShotsMU@FLhealth.gov . Stage 2 has also added cancer reporting to the list of MU public health reporting objectives. More information can be found here: http://fcds.med.miami.edu/inc/MU2FLCancerReporting.shtml .
Meaningful Use states that eligible hospitals must have the capability to submit electronic data on reportable lab results (as required by Rule 64D-3) to public health agencies and actual submission according to applicable law and practice. FDOH and is readily accepting HL7 2.5.1 formatted data as specified by Meaningful Use.
In order to satisfy Florida’s requirements for this Meaningful Use objective hospitals must:
Send inquiries to DLFDOHReportableLabResultsInquiry@flhealth.gov
Meaningful Use states that eligible hospitals including urgent care facilities and eligible professionals must have the capability to submit electronic syndromic surveillance data to public health agencies and actual submission according to applicable law and practice. FDOH is accepting 2.5.1 formatted syndromic surveillance data from emergency departments and urgent care facilities only. At this time, FDOH is not accepting syndromic surveillance data from non-urgent care eligible professionals.
In order to satisfy Florida’s requirements for this Meaningful Use objective hospitals and urgent care centers must:
Send inquiries to DLFDOHSyndromicSurveillanceInquiry@flhealth.gov
As stated in the Medicare and Medicaid Programs EHR Incentive Program Final Rule, follow up submission is a requirement to meet the Meaningful Use objective.
The Agency for Health Care Administration has created a list of some frequently asked questions with information about all of the MU objectives including those related to public health that can be found here: FAQs.
Please contact Hunter Davis at (850) 245-4401 for questions regarding reportable lab results or syndromic surveillance.